Stratec SE
XETRA:SBS
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
26.45
48.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SBS stock under the Base Case scenario is 57.67 EUR. Compared to the current market price of 26.45 EUR, Stratec SE is Undervalued by 54%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Stratec SE
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SBS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Stratec SE
Balance Sheet Decomposition
Stratec SE
Current Assets | 235.5m |
Cash & Short-Term Investments | 35.1m |
Receivables | 51.4m |
Other Current Assets | 149m |
Non-Current Assets | 215.3m |
Long-Term Investments | 3.7m |
PP&E | 81.6m |
Intangibles | 113.5m |
Other Non-Current Assets | 16.5m |
Current Liabilities | 93.4m |
Accounts Payable | 13.1m |
Other Current Liabilities | 80.3m |
Non-Current Liabilities | 129.7m |
Long-Term Debt | 93.6m |
Other Non-Current Liabilities | 36.1m |
Earnings Waterfall
Stratec SE
Revenue
|
250.5m
EUR
|
Cost of Revenue
|
-182.8m
EUR
|
Gross Profit
|
67.8m
EUR
|
Operating Expenses
|
-48.7m
EUR
|
Operating Income
|
19m
EUR
|
Other Expenses
|
-9m
EUR
|
Net Income
|
10m
EUR
|
Free Cash Flow Analysis
Stratec SE
EUR | |
Free Cash Flow | EUR |
SBS Profitability Score
Profitability Due Diligence
Stratec SE's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Stratec SE's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
SBS Solvency Score
Solvency Due Diligence
Stratec SE's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Stratec SE's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SBS Price Targets Summary
Stratec SE
According to Wall Street analysts, the average 1-year price target for SBS is 41.82 EUR with a low forecast of 31.31 EUR and a high forecast of 52.5 EUR.
Dividends
Current shareholder yield for SBS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SBS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Contact
IPO
Employees
Officers
The intrinsic value of one SBS stock under the Base Case scenario is 57.67 EUR.
Compared to the current market price of 26.45 EUR, Stratec SE is Undervalued by 54%.